사회: 김문영 (연세원주의대)
10:00-10:05 | 환영사 | 천갑진 (강원지회 회장) |
10:05-10:10 | 격려사 | 고광철 (대한간학회 회장) |
10:10-12:10 | Session 1. Emerging Concept and Nomenclature Change from FLD to SLD | 김동준 (한림의대) Kenichi Ikejima (Juntendo University School of Medicine) |
10:10-10:35 | Embracing a new concept of steatotic liver disease: alcohol and metabolic dysfunction | Kenichi Ikejima (Juntendo University School of Medicine) |
10:35-11:00 | Glutamate/mGluR5-mediated steatotic liver disease | 정원일 (KAIST) |
11:00-11:25 | Gut dysbiosis in steatotic liver disease | 석기태 (한림의대) |
11:25-11:50 | The role of lipid dynamics in steatotic liver disease | Kazuyoshi Kon (Juntendo University School of Medicine) |
11:50-12:10 | Discussion | |
12:10-13:00 | Lunch | |
13:00-14:40 | Session 2. Current and Future Perspective of ALD | 고광철 (성균관의대), 백순구 (연세원주의대) |
13:00-13:20 | Natural course and prognosis of ALD | 장 영 (순천향의대) |
13:20-13:40 | Gender and socioeconomics differences in ALD | 김태석 (강원의대) |
13:40-14:00 | Comorbidities associated with ALD | 김성은 (한림의대) |
14:00-14:20 | Current landscape of diagnostic and prognostic biomarkers in ALD | 정재연 (아주의대) |
14:20-14:40 | Discussion | |
14:40-14:50 | Break | |
14:50-16:30 | Session 3. Recent Issues in Management of ALD | 배시현 (가톨릭의대), 천갑진 (울산의대) |
14:50-15:10 | Medical treatment of ALD | 최대희 (강원의대) |
15:10-15:30 | Surgical treatment of ALD | 이해원 (서울의대 외과) |
15:30-15:50 | Psychiatric treatment of alcohol use disorders | 이상규 (한림의대 정신과) |
15:50-16:10 | The new era of digital therapeutics in alcohol use disorders | 이승엽 (가톨릭의대 정신과) |
16:10-16:30 | Discussion | |
16:30-16:35 | 맺음말 | 배시현 (대한간학회 이사장) |